Cargando…
Impact of Clinical Pharmacists’ Recommendations on a Proton Pump Inhibitor Taper Protocol in an Ambulatory Care Practice
BACKGROUND: Previous studies have demonstrated an association between chronic proton pump inhibitor (PPI) utilization and adverse events such as fractures, infections, hypomagnesemia, and vitamin B12 deficiency. Because patients taking PPIs for an extended period of time are more susceptible to thes...
Autores principales: | Bundeff, Andrew W., Zaiken, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438075/ https://www.ncbi.nlm.nih.gov/pubmed/23627578 http://dx.doi.org/10.18553/jmcp.2013.19.4.325 |
Ejemplares similares
-
Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009
por: Rotman, Stephen R., et al.
Publicado: (2013) -
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
por: Boardman, Helen F., et al.
Publicado: (2015) -
Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors
por: Alhossan, Abdulaziz, et al.
Publicado: (2019) -
Characteristics of Pharmacists' Interventions Related to Proton-Pump Inhibitors in French Hospitals: An Observational Study
por: Yailian, AL, et al.
Publicado: (2022) -
Use of proton pump inhibitors in general practice
por: Tosetti, Cesare, et al.
Publicado: (2017)